8 Laborne Valle JH, Martins Tavares P, Linhares Trannin

8 Hamza TH, Houwelingen HC, Stijnen T. The binomial distribution of meta-analysis was preferred to model within-study variability. J Clin Epidemiol 2008; 61: 41–51. 9 Higgins JP, Thompson SG. Quantifying heterogeneity in meta-analysis. Stat Med 2002; 21: 1539–58. 10 Glasziou PP, Sanders SL. Investigating causes of heterogeneity in systematic reviews. Stat Med 2002; 21: 1503–11. 11 Thompson SG, SJ Sharp. Explaining heterogeneity in meta-analysis: a comparison of methods. Statist Med 1999; 18: 2693–708. 12 Poppe de Figeuiredo F, Alves Brito A, Laborne Valle JH, Martins Tavares P, Linhares Trannin P. Short duration chemotherapy of pulmonary tuberculosis: a pilot trial. Bull Int Union Tuberc 1974; 49: 382. 13 Hong Kong Tuberculosis Treatment Services/Brompton Hospital/ British Medical Research Council. A controlled clinical trial of daily and intermittent regimens of rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis in Hong Kong. Tubercle 1974; 55: 1–27. 14 Singapore Tuberculosis Service/British Medical Research Council. Controlled trial of intermittent regimens of rifampin plus isoniazid for pulmonary tuberculosis in Singapore. The results up to 30 months. Am Rev Respir Dis 1977; 116: 807–20. 15 Zierski M, Bek E, Bergson H, Kucharska A, Szelagowicz B. Retreatment of chronic pulmonary tuberculosis with regimens including high and low doses of rifampicin in the intermittent phase recent and late results—a controlled comparison study. Bull Int Union Tuberc 1976; 51: 121–26. 16 Third East African/British Medical Research Council. Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis: ? rst report. Am Rev Respir Dis 1978; 118: 39–48. 17 East African/British Medical Research Council. Controlled clinical trial of ? ve short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. Lancet 1978; 312: 334–38. 18 Hong Kong Chest Service/British Medical Research Council. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report. Am Rev Respir Dis 1978; 118: 219–28. 19 Singapore Tuberculosis Service/British Medical Research Council. Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. Am Rev Respir Dis 1979; 119: 579–85. 20 Tripathy SP. Madras study of short-course chemotherapy in pulmonary tuberculosis. Bull Int Union Tuberc 1979; 54: 28–30. 21 Zierski M, Bek E, Long MW, Snider DE Jr. Short-course (6 month) cooperative tuberculosis study in Poland: results 18 months after completion of treatment. Am Rev Respir Dis 1980; 122: 879–89. 22 Hong Kong Chest Service/British Medical Research Council. Controlled trial of four thrice-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis. Lancet 1981; 317: 171–74. 23 East African/British Medical Research Council. Controlled clinical trial of 4 short-couse regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis. Tuberc 1983; 64: 153–66. 24 Algerian Working Group/British Medical Research Council. Controlled clinical trial comparing a 6-month and a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Am Rev Respir Dis 1984; 129: 921–28. 25 Mazouni L, Tazir M, Boulahbal F, Chaulet P. Enquête contrôlée comparant trois règimes de chiniothérapie quotidienne de six mois dans la tuberculose pulmonaire, en pratique de routine à Alger. Rev Mal Resp 1985; 2: 209–14. 26 Singapore Tuberculosis Service/British Medical Research Council. Clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Am Rev Respir Dis 1985; 132: 374–78. 27 Aziz A, Ishaq M, Ja? er NA, Akhwand R, Bhatti AH. Clinical trial of two short-course (6-month) regimens and a standard regimen (12-month) chemotherapy in retreatment of pulmonary tuberculosis in Pakistan. Am Rev Resp Dis 1986; 134: 1056–61. 28 Tanzania/British Medical Research Council. Controlled clinical trial of two 6-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. Am Rev Respir Dis 1985; 131: 727–31.29 Tuberculosis Research Centre Madras. A controlled clinical trial of 3- and 5-month regimens in the treatment of sputum-positive pulmonary tuberculosis in South India. Am Rev Respir Dis 1986; 134: 27–33. 30 Babu SO, Aluoch JA, Githui WA, et al. Controlled clinical trial of a regimen of two durations for the treatment of isoniazid resistant pulmonary tuberculosis. Tubercle 1988; 69: 5–14. 31 Hong YP, Kim SC, Chang SC, Kim SJ, Jin BW, Park CD. Comparison of a daily and three intermittent retreatment regimens for pulmonary tuberculosis administered under programme conditions. Tubercle 1988; 69: 241–53. 32 Castelo A, Jardim JR, Goihman S, et al. Comparison of daily and twice-weekly regimens to treat pulmonary tuberculosis. Lancet 1989; 334: 1173–76. 33 Hong Kong Chest Service/Tuberculosis Research Centre Madras/British Medical Research Council. A controlled trial of 3-month, 4-month, and 6-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Results at 5 years. Am Rev Respir Dis 1989; 139: 871–76. 34 Kenyan/Zambian/British Medical Research Council Collaborative Study. Controlled clinical trial of levamisole in short-course chemotherapy for pulmonary tuberculosis. Am Rev Respir Dis 1989; 140: 990–95. 35 Agounitestane D, Chiheb M, Khaled S, Khaled NA, Boulahbal F, Chaulet P. Essai thérapeutique d’une combinaison de trois médicaments essentiels dans la chimiothérapie courte de la tuberculose. Rev Mal Resp 1990; 7: 209–13. 36 Algerian Working Group/British Medical Research Council Cooperative Study. Short-course chemotherapy for pulmonary tuberculosis under routine programme conditions: a comparison of regimens of 28 and 36 weeks duration in Algeria. Tubercle 1991; 72: 88-100. 37 Hong Kong Chest Service/British Medical Research Council. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Am Rev Respir Dis 1991; 143: 700–06. 38 Hong Kong Chest Service/Tuberculosis Research Centre/Madras/ British Medical Research Council. A controlled clinical comparison of 6 and 8 months of antituberculosis chemotherapy in the treatment of patients with silicotuberculosis in Hong Kong. Am Rev Respir Dis 1991; 143: 262–67. 39 Singapore Tuberculosis Service/British Medical Research Council. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Am Rev Respir Dis 1991; 143: 707–12. 40 Chaulet P, Boulahbal F. Essai clinique d’une combinaison en proportions ? xes de trois medicaments dans le traitement de la tuberculose. Tuberc Lung Dis 1995; 76: 407–412. 41 Tanzania British Medical Research Council Collaborative Investigation. A controlled trial of a 4-weekly supplement of rifampicin, pyrazinamide and streptomycin in the continuation phase of a 7-month daily chemotherapy regimen for pulmonary tuberculosis. S Afr Med J 1996; 86: 960–65. 42 Santha T, Rehman F, Mitchison DA, et al. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis—a unique approach. Trop Med Int Health 2004; 9: 551–58. 43 Swaminathan S, Narendran G, Venkatesan P, et al. E?  cacy of a 6-month versus 9-month intermittent tretment regimen in HIV-infected patients with tuberculosis. Am J Respir Crit Care Med 2010; 181: 743–51. 44 Gyselen A, Verbist L, Cosemans J, Lacquet LM, Vandenbergh E. Rifampin and ethambutol in the retreatment of advanced pulmonary tuberculosis. Am Rev Resp Dis 1968; 98: 933. 45 Mital OP, Narang RK, Sachan AS. Rifampicin-ethambutol in retreatment of pulmonary tuberculosis. Indian J Chest Dis Allied Sci 1976; 18: 141–45. 46 Davies GR, Connolly C, Sturm AW, McAdam K, Wilkinson D. Twice-weekly, directly observed treatment for HIV-infected and uninfected tuberculosis patien

x

Hi!
I'm Josephine!

Would you like to get a custom essay? How about receiving a customized one?

Check it out